Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis.
Joseph T MattinglyStephen MeningerEmily L HeilPublished in: PloS one (2019)
Patients reporting a PCN allergy on admission may receive sub-optimal alternative therapies to beta-lactams, such as vancomycin, for MSSA bacteremia. This economic analysis demonstrates that inpatient PST services confirming PCN allergy are cost-effective for patients with MSSA bacteremia.
Keyphrases
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- emergency department
- healthcare
- mental health
- ejection fraction
- newly diagnosed
- primary care
- gram negative
- prognostic factors
- cystic fibrosis
- patient reported outcomes
- adverse drug
- infectious diseases
- soft tissue
- drug induced
- electronic health record
- data analysis